Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FEMQF
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $163,578
Award facts
- Contract value 100% obligated
- $163,578.35 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $163,578.35 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued on January 5, 2026, with an ultimate completion date of January 6, 2026, was awarded without set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group operates as a critical supplier within the federal pharmaceutical supply chain, specializing in distributing comprehensive ranges of branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, specialty pharmaceuticals, and medical consumables to support Department of Defense healthcare operations.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion government-wide acquisition strategy designed to establish multiple regional prime vendor contractors. The underlying IDC, valued at $499,999,999 and effective through December 31, 2036, authorizes DLA to issue firm fixed-price delivery orders for pharmaceutical products and medical consumables to support recurring medical supply needs of military healthcare facilities worldwide. The contractor has demonstrated substantial federal contracting activity through numerous delivery orders issued by DLA's Medical Supply Chain division, with no identified subcontractor relationships.
Quick answers
Who was awarded contract SPE2DU26FEMQF?
SPE2DU26FEMQF was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 5, 2026.
How much is contract SPE2DU26FEMQF worth?
The government has obligated $163,578 on SPE2DU26FEMQF.
Is contract SPE2DU26FEMQF an order under another contract?
Yes. SPE2DU26FEMQF is a delivery order under SPE2DU25D9517, an indefinite delivery contract.
Was contract SPE2DU26FEMQF competed?
The extent of competition for SPE2DU26FEMQF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award